Report of the 14th International Conference on Malignant Lymphoma (ICML) closed workshop on future design of clinical trials in lymphomas Journal Article


Authors: Stathis, A.; Iasonos, A.; Seymour, J. F.; Thieblemont, C.; Ribrag, V.; Zucca, E.; Younes, A.
Article Title: Report of the 14th International Conference on Malignant Lymphoma (ICML) closed workshop on future design of clinical trials in lymphomas
Abstract: The 14th ICML held in Lugano in June 2017 was preceded by a closed workshop (organized in collaboration with the American Association for Cancer Research and the European School of Oncology) where experts in preclinical and clinical research in lymphomas met to discuss the current drug development landscape focusing on critical open questions that need to be addressed in the future to permit a more efficient drug development paradigm in lymphoma. Topics discussed included both preclinical models that can be used to test new drugs and drug combinations, as well as the optimal design of clinical trials and the endpoints that should be used to facilitate accelerated progress. This report represents a summary of the workshop. © 2018 AACR.
Journal Title: Clinical Cancer Research
Volume: 24
Issue: 13
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2018-07-01
Start Page: 2993
End Page: 2998
Language: English
DOI: 10.1158/1078-0432.ccr-17-3021
PROVIDER: scopus
PUBMED: 29535129
DOI/URL:
Notes: Review -- Export Date: 1 August 2018 -- Source: Scopus
Altmetric Score
MSK Authors
  1. Alexia Elia Iasonos
    169 Iasonos
  2. Anas Younes
    187 Younes